{
  "id": 4425,
  "url": "https://nnemf.org/research/4425-investigation-on-the-migration-and-biologic-effects-of",
  "title": "[Investigation on the migration and biologic effects of nano FeOx powders under the exposure of extremely low frequency altering electric magnetic field in human heptoma-bearing nude mice in vivo].",
  "authors": [
    "Hui-Xiang Ju",
    "Zhen-Yu Dai",
    "Ming-Zhong Sun"
  ],
  "journal": "Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology",
  "year": "2011",
  "doi": "10.3760/cma.j.issn.1007-3418.2011.08.009",
  "pmid": "22152316",
  "abstract": "To investigate the mechanism and biologic effects of 37 nm magnetic nano FeOx powders (MNPs) on human hepatoma-bearing nude mice. 37 nm MNPs were prepared by coprecipitation methods and then injected into human hepatoma (Bel-7402) bearing-nude mice through the tail vein. After injection of MNPs, the mice were first exposed under static magnetic field and then treated under extremely low frequency altering-electric magnetic field directing to the tumor area. The migration and trafficking of MNPs were determined by MMR. Tumor growth was monitored with calipers every 5 days and tumor volume was calculated on the basis of three-dimensioned measurements. The apoptosis of tumor cells was analyzed by flow cytometry analysis. The expressions of apoptosis-associated proteins Bcl-2, Bax and HSP27 were determined using western-blot analysis. Static magnetic field could direct the migration and trafficking of MNPs to the tumor site with a higher ratio of 98.9%. Extremely Low Frequency Electric-Magnetic Field (EMF) treatment could inhibit the proliferation of tumor cells and prolong the survive time of tumor-bearing mice injected with MNPs. In addition, the survival time of tumor-bearing mice and percentages of prohibition on tumor cell growth were 27.4+/-0.7 days and 37.5+/-0.8% (F = 0.005, P is less than to 0.05), respectively. The results of flow cytometry analyses showed that about 18.1+/-0.6% (F = 0.030, P is less than to 0.05) of tumor cells were induced into early apoptosis. Furthermore, expressions of apoptosis-associated proteins Bcl-2 and Bax were significantly induced by MNPs under EMF treatment. The ratio of Bcl/Bax in both MNPs and EMF treatment group was 0.07+/-0.01, which was much lower than that of control group (0.23+/-0.02) (F = 0.016, P is less than to 0.05). Heat shock protein-27 (Hsp-27) was not significantly induced in different treatment groups. Injection of MNPs with EMF exposure on human hepatoma-bearing nude mice could significantly prolong the survival time, inhibit the tumor proliferation and growth, and induce tumor cells into apoptosis.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Human hepatoma (Bel-7402) bearing nude mice",
    "sampleSize": "—",
    "exposure": "ELF <1 MHz",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Static magnetic field directed migration/trafficking of 37 nm magnetic nano FeOx powders to the tumor site with a reported ratio of 98.9%. Subsequent extremely low frequency altering electric-magnetic field treatment (with MNP injection) was associated with inhibited tumor cell proliferation, prolonged survival time (27.4±0.7 days), increased early apoptosis (~18.1±0.6%), and altered Bcl-2/Bax (lower Bcl/Bax ratio vs control), while Hsp-27 was not significantly induced.",
    "outcomes": [
      "Migration/trafficking of magnetic nano FeOx powders (MNPs) to tumor site",
      "Tumor growth/volume",
      "Survival time",
      "Tumor cell proliferation inhibition",
      "Tumor cell apoptosis (early apoptosis by flow cytometry)",
      "Expression of apoptosis-associated proteins (Bcl-2",
      "Bax)",
      "Expression of HSP27"
    ],
    "limitations": [
      "No sample size reported in abstract",
      "Exposure parameters (ELF frequency",
      "field strength",
      "duration) not reported in abstract",
      "Intervention includes both nanoparticle injection and magnetic/EMF exposure",
      "effects of EMF alone cannot be separated from MNPs and static magnetic field",
      "Animal tumor model",
      "generalizability to humans is uncertain"
    ],
    "keywords": [
      "extremely low frequency",
      "electric-magnetic field",
      "static magnetic field",
      "magnetic nanoparticles",
      "FeOx",
      "nude mice",
      "hepatoma",
      "Bel-7402",
      "apoptosis",
      "Bcl-2",
      "Bax",
      "HSP27",
      "tumor growth",
      "survival"
    ],
    "hubs": [
      {
        "slug": "occupational-exposure",
        "weight": "0.7",
        "reason": "Mentions extremely low frequency EMF exposure, but context is experimental tumor treatment rather than occupational settings."
      }
    ],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": \"other\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Human hepatoma (Bel-7402) bearing nude mice\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Migration/trafficking of magnetic nano FeOx powders (MNPs) to tumor site\",\n    \"Tumor growth/volume\",\n    \"Survival time\",\n    \"Tumor cell proliferation inhibition\",\n    \"Tumor cell apoptosis (early apoptosis by flow cytometry)\",\n    \"Expression of apoptosis-associated proteins (Bcl-2, Bax)\",\n    \"Expression of HSP27\"\n  ],\n  \"main_findings\": \"Static magnetic field directed migration/trafficking of 37 nm magnetic nano FeOx powders to the tumor site with a reported ratio of 98.9%. Subsequent extremely low frequency altering electric-magnetic field treatment (with MNP injection) was associated with inhibited tumor cell proliferation, prolonged survival time (27.4±0.7 days), increased early apoptosis (~18.1±0.6%), and altered Bcl-2/Bax (lower Bcl/Bax ratio vs control), while Hsp-27 was not significantly induced.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"No sample size reported in abstract\",\n    \"Exposure parameters (ELF frequency, field strength, duration) not reported in abstract\",\n    \"Intervention includes both nanoparticle injection and magnetic/EMF exposure; effects of EMF alone cannot be separated from MNPs and static magnetic field\",\n    \"Animal tumor model; generalizability to humans is uncertain\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low frequency\",\n    \"electric-magnetic field\",\n    \"static magnetic field\",\n    \"magnetic nanoparticles\",\n    \"FeOx\",\n    \"nude mice\",\n    \"hepatoma\",\n    \"Bel-7402\",\n    \"apoptosis\",\n    \"Bcl-2\",\n    \"Bax\",\n    \"HSP27\",\n    \"tumor growth\",\n    \"survival\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"occupational-exposure\",\n      \"weight\": 0.05,\n      \"reason\": \"Mentions extremely low frequency EMF exposure, but context is experimental tumor treatment rather than occupational settings.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/22152316/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=4425",
  "updated": "2026-02-14 07:45:00"
}